Konstantinos Xynos has sold REPL and made no open-market buys since Nov 2023
Chief Medical Officer at Replimune Group, Inc.
SEC CIK 0001956241 · Filings on SEC.gov ↗
$0Bought
$538KSold
NoneLast buy
Every filing
6 filings since Nov 2023, newest first
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$148K−4.9%Aug 12
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$71K−5.6%May 20
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$78K−6.0%Nov 20
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$119K−12.0%Jun 10
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$41K−5.0%May 20
REPLSell
Replimune Group, Inc.
Chief Medical Officer
$80K−6.0%Nov 17
Filings come from SEC EDGAR. Not investment advice.